UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...

According to the Korea Centers for Disease Control and Prevention, the spread of influenza this year is much faster than in previous years. As of the 43rd week of 2025 (October 19-25), the proportion ...

This novel therapy offers the first FDA-approved option to address the root cause of this ultra-rare condition, which causes progressive muscle weakness impairing walking, breathing, and swallowing.

In a hut built with bamboo walls and thatched roofing, the family of Buchan Saday from Ward 5 of Chinnamasta Rural Municipality, Saptari, is in mourning. Within a week, three members of his 8-member ...